Choice of Moisturiser for Eczema Treatment (COMET): Study protocol for a randomized controlled trial

Matthew J. Ridd, Niamh M. Redmond, Sandra Hollinghurst, Nicola Ball, Lindsay Shaw, Richard Guy, Victoria Wilson, Chris Metcalfe, Sarah Purdy

Research output: Contribution to journalArticle

13 Citations (Scopus)
79 Downloads (Pure)

Abstract

Background: Eczema is common in children and in the UK most cases are managed in primary care. The foundation of all treatment is the regular use of leave-on emollients to preserve and restore moisture to the skin. This not only improves comfort but may also reduce the need for rescue treatment for 'flares', such as topical corticosteroids. However, clinicians can prescribe many different types of emollient and there is a paucity of evidence to guide this choice. One reason for this may be the challenges of conducting a clinical trial: are parents or carers of young children willing to be randomly allocated an emollient and followed up for a meaningful amount of time? Design: This is a single-centre feasibility study of a pragmatic, four-arm, single-masked, randomized trial. Children with eczema who are eligible (from 1 month to less than 5 years of age, not known to be sensitive or allergic to any of study emollients or their constituents) are recruited via their general practices. Participants are allocated Aveeno® lotion, Diprobase® cream, Doublebase® gel or Hydromol® ointment via a web-based system, using a simple randomization process in a 1:1:1:1 fashion. Researchers are masked to the study emollient. Participants are assessed at baseline and followed up for 3 months. Data are collected by daily diaries, monthly researcher visits and review of electronic medical records. Because this is a feasibility study, a formal sample size calculation for the estimation of treatment effectiveness has not be made but we aim to recruit 160 participants. Discussion: Recruitment is on-going. At the end of the study, as well as being able to answer the question, 'Is it is possible to recruit and retain children with eczema from primary care into a four-arm randomized trial of emollients?', we will also have collected important data on the acceptability and effectiveness of four commonly used emollients. Trial registration: Current Controlled Trials ISRCTN21828118, and Clinical Trials Register EudraCT2013-003001-26.

Original languageEnglish
Article number304
JournalTrials
Volume16
DOIs
Publication statusPublished - 15 Jul 2015

Fingerprint

Emollients
Eczema
Clinical Protocols
Randomized Controlled Trials
Feasibility Studies
Primary Health Care
Research Personnel
Clinical Trials
Electronic Health Records
Random Allocation
Ointments
General Practice
Sample Size
Caregivers
Adrenal Cortex Hormones
Parents
Gels
Skin
Therapeutics

Keywords

  • children
  • eczema
  • emollients
  • feasibility
  • primary care
  • RCT

Cite this

Ridd, M. J., Redmond, N. M., Hollinghurst, S., Ball, N., Shaw, L., Guy, R., ... Purdy, S. (2015). Choice of Moisturiser for Eczema Treatment (COMET): Study protocol for a randomized controlled trial. Trials, 16, [304]. https://doi.org/10.1186/s13063-015-0830-y

Choice of Moisturiser for Eczema Treatment (COMET) : Study protocol for a randomized controlled trial. / Ridd, Matthew J.; Redmond, Niamh M.; Hollinghurst, Sandra; Ball, Nicola; Shaw, Lindsay; Guy, Richard; Wilson, Victoria; Metcalfe, Chris; Purdy, Sarah.

In: Trials, Vol. 16, 304, 15.07.2015.

Research output: Contribution to journalArticle

Ridd, MJ, Redmond, NM, Hollinghurst, S, Ball, N, Shaw, L, Guy, R, Wilson, V, Metcalfe, C & Purdy, S 2015, 'Choice of Moisturiser for Eczema Treatment (COMET): Study protocol for a randomized controlled trial', Trials, vol. 16, 304. https://doi.org/10.1186/s13063-015-0830-y
Ridd, Matthew J. ; Redmond, Niamh M. ; Hollinghurst, Sandra ; Ball, Nicola ; Shaw, Lindsay ; Guy, Richard ; Wilson, Victoria ; Metcalfe, Chris ; Purdy, Sarah. / Choice of Moisturiser for Eczema Treatment (COMET) : Study protocol for a randomized controlled trial. In: Trials. 2015 ; Vol. 16.
@article{54103ab7604447fe9b3998e75a172c6d,
title = "Choice of Moisturiser for Eczema Treatment (COMET): Study protocol for a randomized controlled trial",
abstract = "Background: Eczema is common in children and in the UK most cases are managed in primary care. The foundation of all treatment is the regular use of leave-on emollients to preserve and restore moisture to the skin. This not only improves comfort but may also reduce the need for rescue treatment for 'flares', such as topical corticosteroids. However, clinicians can prescribe many different types of emollient and there is a paucity of evidence to guide this choice. One reason for this may be the challenges of conducting a clinical trial: are parents or carers of young children willing to be randomly allocated an emollient and followed up for a meaningful amount of time? Design: This is a single-centre feasibility study of a pragmatic, four-arm, single-masked, randomized trial. Children with eczema who are eligible (from 1 month to less than 5 years of age, not known to be sensitive or allergic to any of study emollients or their constituents) are recruited via their general practices. Participants are allocated Aveeno{\circledR} lotion, Diprobase{\circledR} cream, Doublebase{\circledR} gel or Hydromol{\circledR} ointment via a web-based system, using a simple randomization process in a 1:1:1:1 fashion. Researchers are masked to the study emollient. Participants are assessed at baseline and followed up for 3 months. Data are collected by daily diaries, monthly researcher visits and review of electronic medical records. Because this is a feasibility study, a formal sample size calculation for the estimation of treatment effectiveness has not be made but we aim to recruit 160 participants. Discussion: Recruitment is on-going. At the end of the study, as well as being able to answer the question, 'Is it is possible to recruit and retain children with eczema from primary care into a four-arm randomized trial of emollients?', we will also have collected important data on the acceptability and effectiveness of four commonly used emollients. Trial registration: Current Controlled Trials ISRCTN21828118, and Clinical Trials Register EudraCT2013-003001-26.",
keywords = "children, eczema, emollients, feasibility, primary care, RCT",
author = "Ridd, {Matthew J.} and Redmond, {Niamh M.} and Sandra Hollinghurst and Nicola Ball and Lindsay Shaw and Richard Guy and Victoria Wilson and Chris Metcalfe and Sarah Purdy",
year = "2015",
month = "7",
day = "15",
doi = "10.1186/s13063-015-0830-y",
language = "English",
volume = "16",
journal = "Trials",
issn = "1745-6215",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Choice of Moisturiser for Eczema Treatment (COMET)

T2 - Study protocol for a randomized controlled trial

AU - Ridd, Matthew J.

AU - Redmond, Niamh M.

AU - Hollinghurst, Sandra

AU - Ball, Nicola

AU - Shaw, Lindsay

AU - Guy, Richard

AU - Wilson, Victoria

AU - Metcalfe, Chris

AU - Purdy, Sarah

PY - 2015/7/15

Y1 - 2015/7/15

N2 - Background: Eczema is common in children and in the UK most cases are managed in primary care. The foundation of all treatment is the regular use of leave-on emollients to preserve and restore moisture to the skin. This not only improves comfort but may also reduce the need for rescue treatment for 'flares', such as topical corticosteroids. However, clinicians can prescribe many different types of emollient and there is a paucity of evidence to guide this choice. One reason for this may be the challenges of conducting a clinical trial: are parents or carers of young children willing to be randomly allocated an emollient and followed up for a meaningful amount of time? Design: This is a single-centre feasibility study of a pragmatic, four-arm, single-masked, randomized trial. Children with eczema who are eligible (from 1 month to less than 5 years of age, not known to be sensitive or allergic to any of study emollients or their constituents) are recruited via their general practices. Participants are allocated Aveeno® lotion, Diprobase® cream, Doublebase® gel or Hydromol® ointment via a web-based system, using a simple randomization process in a 1:1:1:1 fashion. Researchers are masked to the study emollient. Participants are assessed at baseline and followed up for 3 months. Data are collected by daily diaries, monthly researcher visits and review of electronic medical records. Because this is a feasibility study, a formal sample size calculation for the estimation of treatment effectiveness has not be made but we aim to recruit 160 participants. Discussion: Recruitment is on-going. At the end of the study, as well as being able to answer the question, 'Is it is possible to recruit and retain children with eczema from primary care into a four-arm randomized trial of emollients?', we will also have collected important data on the acceptability and effectiveness of four commonly used emollients. Trial registration: Current Controlled Trials ISRCTN21828118, and Clinical Trials Register EudraCT2013-003001-26.

AB - Background: Eczema is common in children and in the UK most cases are managed in primary care. The foundation of all treatment is the regular use of leave-on emollients to preserve and restore moisture to the skin. This not only improves comfort but may also reduce the need for rescue treatment for 'flares', such as topical corticosteroids. However, clinicians can prescribe many different types of emollient and there is a paucity of evidence to guide this choice. One reason for this may be the challenges of conducting a clinical trial: are parents or carers of young children willing to be randomly allocated an emollient and followed up for a meaningful amount of time? Design: This is a single-centre feasibility study of a pragmatic, four-arm, single-masked, randomized trial. Children with eczema who are eligible (from 1 month to less than 5 years of age, not known to be sensitive or allergic to any of study emollients or their constituents) are recruited via their general practices. Participants are allocated Aveeno® lotion, Diprobase® cream, Doublebase® gel or Hydromol® ointment via a web-based system, using a simple randomization process in a 1:1:1:1 fashion. Researchers are masked to the study emollient. Participants are assessed at baseline and followed up for 3 months. Data are collected by daily diaries, monthly researcher visits and review of electronic medical records. Because this is a feasibility study, a formal sample size calculation for the estimation of treatment effectiveness has not be made but we aim to recruit 160 participants. Discussion: Recruitment is on-going. At the end of the study, as well as being able to answer the question, 'Is it is possible to recruit and retain children with eczema from primary care into a four-arm randomized trial of emollients?', we will also have collected important data on the acceptability and effectiveness of four commonly used emollients. Trial registration: Current Controlled Trials ISRCTN21828118, and Clinical Trials Register EudraCT2013-003001-26.

KW - children

KW - eczema

KW - emollients

KW - feasibility

KW - primary care

KW - RCT

UR - http://www.scopus.com/inward/record.url?scp=84937022189&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1186/s13063-015-0830-y

U2 - 10.1186/s13063-015-0830-y

DO - 10.1186/s13063-015-0830-y

M3 - Article

VL - 16

JO - Trials

JF - Trials

SN - 1745-6215

M1 - 304

ER -